Leukemia Archives | Report Store | Pharma intelligence

Disease Analysis: Acute Myeloid Leukemia (AML)

AML is a type of heterogeneous hematological malignancy that originates from immature white blood cells (blasts) in the bone marrow, which may be derived from either a hematopoietic stem cell or a lineage-specific progenitor cell. “Acute” means that the leukemia may progress rapidly – AML generally spreads quickly to the bloodstream and can then spread to other parts of the body including the lymph nodes, spleen, central nervous system, and testicles.

February 19, 2021

Find out more

Market Spotlight: Acute Lymphoblastic Leukemia (ALL)

$1,318.00

This Market Spotlight report covers the Acute Lymphoblastic Leukemia (ALL) market, comprising key marketed and pipeline drugs, clinical trials, recent events and analyst opinion, upcoming events, probability of success, a 10-year disease incidence forecast, and licensing and acquisition deals, as well as presenting drug-specific revenue forecasts.

February 18, 2021

Find out more

Chronic Lymphocytic Leukemia (CLL)

Chronic lymphocytic leukemia (CLL) is a disease characterized by an accumulation of mature malignant B lymphocytes in the peripheral blood, bone marrow, and lymph nodes.

October 23, 2019

Find out more

Acute Lymphobastic Leukemia (ALL) Forecast and Market Analysis to 2024

Acute lymphoblastic leukemia (ALL) is a hematological disease that is characterized by the proliferation of immature lymphoid cells in the bone marrow and peripheral blood. ALL is typically a disease of childhood, with over 70% of cases affecting children.

July 5, 2018

Find out more

Chronic Myeloid Leukemia (CML)

Chronic myeloid leukemia (CML), also known as chronic myelogenous leukemia, is a myeloproliferative disorder characterized by a single cytogenetic hallmark.

December 7, 2017

Find out more